Hutch News
Results per Page:
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
When more is more: Increased levels of wild-type and mutant RIT1 promote oncogenesis
From the Berger Lab, Human Biology Division
Omics made easier
To see the big picture, just add ‘ome’
Squelching ovarian cancer: the not-so-silent killer
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease
Good News: Fred Hutch scientists to develop bioassay for ovarian cancer for new NCI initiative
Celebrating faculty and staff achievements
Proteowhatnow? 6 questions with a proteomics expert
How a new technology could help identify the best cancer treatment for an individual patient
Good News: Communications & Marketing wins 12 creativity awards
Celebrating faculty and staff achievements
Good News: Dr. Jeff Whiteaker wins NCI Research Specialist Award; Human Biology gains four new faculty members
Celebrating faculty and staff achievements
Paulovich Lab's proteomic platform presented at personalized medicine conference
Celebrating faculty and staff achievements
SCIEX to commercialize targeted proteomics technology developed in Paulovich Lab
Collaboration aims to make targeted proteomics in cancer research more reproducible, specific